-
Glycogen synthase kinase-3: properties, functions, and regulation.
Division of Experimental Therapeutics, Ontario Cancer Institute, 610-University Avenue, Toronto, Ontario, Canada M5G 2M9. aali@uwindsor.ca
PMID: 11749387 [PubMed - indexed for MEDLINE]
-
Cited by 23 PubMed Central articles
-
Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
Mamaghani S, Patel S, Hedley DW.
BMC Cancer. 2009 Apr 30; 9:132. Epub 2009 Apr 30.
[BMC Cancer. 2009]
-
Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.
Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA.
Mol Cell Biol. 2008 Dec; 28(24):7309-22. Epub 2008 Oct 6.
[Mol Cell Biol. 2008]
-
Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, et al.
Mol Cell Biol. 2008 Dec; 28(23):7236-44. Epub 2008 Sep 29.
[Mol Cell Biol. 2008]
- » See all...